The spindle cell/sclerosing subtype of rhabdomyosarcoma is classified based on genetic features into the three categories of MYOD1-mutated, gene fusion-driven, and a subset without a currently identified genetic driver event. The gene fusion-driven spindle cell/sclerosing rhabdomyosarcomas are heterogenous and characterized by increasing numbers of gene fusions, the most common gene partners being VGLL2, NCOA2, and TFCP2. Here we report a spindle cell/sclerosing rhabdomyosarcoma that arose in the orbit of a 4-year-old male. This tumor harbored a unique PAX8::PPARG fusion. PAX8::PPARG fusions have previously only been described in follicular thyroid carcinoma and follicular variant of papillary thyroid carcinoma. Our report adds to the growing number of gene fusions in spindle cell/sclerosing rhabdomyosarcomas.
LeinerJLe LoarerF. The current landscape of rhabdomyosarcomas: an update. Virchows Arch. Jan 2020;476(1):97-108. doi:10.1007/s00428-019-02676-9
2.
KuboTShimoseSFujimoriJFurutaTOchiM. Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: systematic review and meta-analysis. Crit Rev Oncol Hematol. Oct 2015;96(1):46-53. doi:10.1016/j.critrevonc.2015.04.012
3.
SorensenPHLynchJCQualmanSJ, et al.PAX3-FKHR And PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. Jun 1 2002;20(11):2672-2679. doi:10.1200/JCO.2002.03.137
4.
DuanFSmithLMGustafsonDM, et al.Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the children's oncology group. Genes Chromosomes Cancer. Jul 2012;51(7):662-674. doi:10.1002/gcc.21953
5.
AgaramNPHuangSCTapWDWexlerLHAntonescuCR. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations. Genes Chromosomes Cancer. Nov. 9 2021;61(3):131-137. doi:10.1002/gcc.23010
6.
KebudiRDuralOBaySB, et al.Childhood rhabdomyosarcoma of the female genital tract: association with pathogenic dicer1 variation, clinicopathological features, and outcomes. J Pediatr Adolesc Gynecol. Aug 2021;34(4):449-453. doi:10.1016/j.jpag.2021.01.011
7.
BennettJAOrduluZYoungRH, et al.Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations. Mod Pathol. Sep 2021;34(9):1750-1762. doi:10.1038/s41379-021-00821-x
8.
McCluggageWGApellaniz-RuizMChongAL, et al.Embryonal rhabdomyosarcoma of the ovary and fallopian tube: rare neoplasms associated with germline and somatic DICER1 mutations. Am J Surg Pathol. Jun 2020;44(6):738-747. doi:10.1097/PAS.0000000000001442
9.
GuillouLAuriasA. Soft tissue sarcomas with complex genomic profiles. Virchows Arch. Feb 2010;456(2):201-217. doi:10.1007/s00428-009-0853-4
10.
LiGOgoseAKawashimaH, et al.Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma. Cancer Genet Cytogenet. Jul 2009;192(1):1-9. doi:10.1016/j.cancergencyto.2009.02.011
11.
ChrisingerJSAWehrliBDicksonBC, et al.Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases. Virchows Arch. Nov 2020;477(5):725-732. doi:10.1007/s00428-020-02870-0
12.
Montoya-CerrilloDMDiaz-PerezJAVelez-TorresJMMontgomeryEARosenbergAE. Novel fusion genes in spindle cell rhabdomyosarcoma: the spectrum broadens. Genes Chromosomes Cancer. Oct 2021;60(10):687-694. doi:10.1002/gcc.22978
13.
AlaggioRZhangLSungYS, et al.A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases. Am J Surg Pathol. Feb 2016;40(2):224-235. doi:10.1097/PAS.0000000000000538
14.
CordierFAmelootEDhoogeC, et al.Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas!. Pathology. Dec 2021;53(7):936-939. doi:10.1016/j.pathol.2021.02.009
15.
RamanPKoenigRJ. PAX-8-PPAR-γ fusion protein in thyroid carcinoma. Nat Rev Endocrinol. Oct 2014;10(10):616-623. doi:10.1038/nrendo.2014.115
16.
ReddiHVMcIverBGrebeSKEberhardtNL. The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis. Endocrinology. Mar 2007;148(3):932-935. doi:10.1210/en.2006-0926
17.
ZhangYYuJLeeCXuBSartorMAKoenigRJ. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein. Oncotarget. Dec 1 2015;6(38):40418-40432. doi:10.18632/oncotarget.6340
18.
GarciaRPatelNUddinNParkJY. Development and clinical validation of a multiplex gene fusion assay. Lab Med. Sep 1 2020;51(5):512-518. doi:10.1093/labmed/lmz102
19.
ChenSRudzinskiERArnoldMA. Challenges in the diagnosis of pediatric spindle cell/sclerosing rhabdomyosarcoma. Surg Pathol Clin. Dec 2020;13(4):729-738. doi:10.1016/j.path.2020.08.010
20.
AgaramNPLaQuagliaMPAlaggioR, et al.MYOD1-mutant Spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Mod Pathol. Jan 2019;32(1):27-36. doi:10.1038/s41379-018-0120-9
21.
RekhiBUpadhyayPRamtekeMPDuttA. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Mod Pathol. Dec 2016;29(12):1532-1540. doi:10.1038/modpathol.2016.144
22.
Le LoarerFClevenAHGBouvierC, et al.A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Mod Pathol. Mar 2020;33(3):404-419. doi:10.1038/s41379-019-0323-8
23.
ThompsonBDavidsonEALiuW, et al.Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease. Hum Genet. Mar 2021;140(3):381-400. doi:10.1007/s00439-020-02212-9
24.
BlakeJAZimanMR. Pax genes: regulators of lineage specification and progenitor cell maintenance. Development. Feb 2014;141(4):737-751. doi:10.1242/dev.091785
25.
MahajanPLeaveyPJGalindoRL. PAX Genes in childhood oncogenesis: developmental biology gone awry?Oncogene. May 21 2015;34(21):2681-2689. doi:10.1038/onc.2014.209
26.
KhizerKPaddaJKhedrA, et al.Paired-box gene 8 (PAX8) and its association with epithelial carcinomas. Cureus. Aug 2021;13(8):e17208. doi:10.7759/cureus.17208
27.
FanR. PAX Immunoreactivity in poorly differentiated small round cell tumors of childhood. Fetal Pediatr Pathol. Aug 2014;33(4):244-252. doi:10.3109/15513815.2014.920441
28.
JoVYMarino-EnriquezAFletcherCDMHornickJL. Expression of PAX3 distinguishes biphenotypic sinonasal sarcoma from histologic mimics. Am J Surg Pathol. Oct 2018;42(10):1275-1285. doi:10.1097/PAS.0000000000001092
29.
WuNWangXChengK, et al.Clinicopathological and molecular features of biphenotypic sinonasal sarcoma. Zhonghua Bing Li Xue Za Zhi. Dec 8 2020;49(12):1261-1266. doi:10.3760/cma.j.cn112151-20200313-00200
30.
MiyachiH. Structural biology-based exploration of subtype-selective agonists for peroxisome proliferator-activated receptors. Int J Mol Sci. Aug 26 2021;22(17):9223. doi:10.3390/ijms22179223
31.
Grygiel-GorniakB. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review. Nutr J. Feb 14 2014;13(1):17. doi:10.1186/1475-2891-13-17
32.
ChengHSYipYSLimEKYWahliWTanNS. PPARs and tumor microenvironment: the emerging roles of the metabolic master regulators in tumor stromal-epithelial crosstalk and carcinogenesis. Cancers (Basel). Apr 29 2021;13(9):2153. doi:10.3390/cancers13092153
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
